Sarcopenia: Pharmacology of today and tomorrow

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 3, 2012, Pages 540-546

  Brotto, Marco ^a   Abreu, Eduardo L ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CALCIUM; CYCLOPHILIN D INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH HORMONE; ISOMERASE INHIBITOR; MYOSTATIN; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PRASTERONE; PROTEASOME INHIBITOR; TESTOSTERONE; UNCLASSIFIED DRUG; URSOLIC ACID; VITAMIN D;

ACNE; ANKLE EDEMA; ANOREXIA; ARTHRALGIA; BITTER TASTE; CARPAL TUNNEL SYNDROME; CLINICAL EFFECTIVENESS; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE PREDISPOSITION; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG STRUCTURE; ENVIRONMENTAL FACTOR; EXERCISE; FATIGUE; GENETIC ASSOCIATION; GINGIVA DISEASE; GINGIVA PAIN; GINGIVITIS; GRIP STRENGTH; GUM TENDERNESS; HAIR LOSS; HEALTH CARE COST; HODGKIN DISEASE; HUMAN; INJECTION SITE REACTION; INTERVENTION STUDY; JOINT SWELLING; LEG EDEMA; LIBIDO; MICTURITION DISORDER; MINOR AFFECTIVE DISORDER; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; NAUSEA; PAINFUL ERECTION; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SHORT STATURE; SIDE EFFECT; SLEEP DISORDERED BREATHING; STOMACH PAIN; TESTIS; TREATMENT OUTCOME; URINE COLOR; WEIGHT GAIN;

AGING; ANIMALS; DIET; HUMANS; MUSCLE STRENGTH; MUSCLE, SKELETAL; RESISTANCE TRAINING; SARCOPENIA;

EID: 84869217927     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.191759     Document Type: Review

References (72)

1. Albuquerque-Silva J, Vassart G, Lavinha J, and Abramowicz MJ (2001) Chimeraplasty validation. Nat Biotechnol 19:1011.
2. Andersson DC and Marks AR (2010) Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug Discov Today Dis Mech 7:e151-e157.
3. Attaix D, Mosoni L, Dardevet D, Combaret L, Mirand PP, and Grizard J (2005) Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods. Int J Biochem Cell Biol 37:1962-1973. (Pubitemid 41206814)
4. Baker WL, Karan S, and Kenny AM (2011) Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review. J Am Geriatr Soc 59:997-1002.
5. Beehler BC, Sleph PG, Benmassaoud L, and Grover GJ (2006) Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation. Exp Biol Med (Maywood) 231:335-341. (Pubitemid 43334321)
6. Bossola M, Pacelli F, Costelli P, Tortorelli A, Rosa F, and Doglietto GB (2008) Proteasome activities in the rectus abdominis muscle of young and older individuals. Biogerontology 9:261-268.
7. Brault JJ, Jespersen JG, and Goldberg AL (2010) Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy. J Biol Chem 285:19460-19471.
8. Brotto M (2011) Aging, sarcopenia and store-operated calcium entry: a common link? Cell Cycle 10:4201-4202.
9. Calder PC (2003) n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38:343-352.
10. Carter CS and Groban L (2008) Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction. Aging Health 4:37-46. (Pubitemid 351260118)
11. Chen PJ, Lin MH, Peng LN, Liu CL, Chang CW, Lin YT, and Chen LK (2012) Predicting cause-specific mortality of older men living in the veterans home by handgrip strength and walking speed: a 3-year, prospective cohort study in Taiwan. J Am Med Dir Assoc 13:517-521.
12. Chumlea WC, Cesari M, Evans WJ, Ferrucci L, Fielding RA, Pahor M, Studenski S, Vellas B, and International Working Group on Sarcopenia Task Force Members (2011) Sarcopenia: designing phase IIB trials. J Nutr Health Aging 15:450-455.
13. Close GL, Kayani A, Vasilaki A, and McArdle A (2005) Skeletal muscle damage with exercise and aging. Sports Med 35:413-427. (Pubitemid 40806941)
14. Cole-Strauss A, Gamper H, Holloman WK, Muñoz M, Cheng N, and Kmiec EB (1999) Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res 27:1323-1330. (Pubitemid 29206442)
15. Cole-Strauss A, Nöe A, and Kmiec EB (1997) Recombinational repair of genetic mutations. Antisense Nucleic Acid Drug Dev 7:211-216. (Pubitemid 27323082)
16. Cole-Strauss A, Yoon K, Xiang Y, Byrne BC, Rice MC, Gryn J, Holloman WK, and Kmiec EB (1996) Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 273:1386-1389. (Pubitemid 26296526)
17. Combaret L, Dardevet D, Béchet D, Taillandier D, Mosoni L, and Attaix D (2009) Skeletal muscle proteolysis in aging. Curr Opin Clin Nutr Metab Care 12:37-41.
18. Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber CC, Kaufman JM, Abellan van Kan G, Boonen S, et al. (2012) Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 23:1839-1848.
19. Copeland JL, Consitt LA, and Tremblay MS (2002) Hormonal responses to endurance and resistance exercise in females aged 19-69 years. J Gerontol A Biol Sci Med Sci 57:B158-B165. (Pubitemid 34263293)
20. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412-423.
21. Febbraio MA and Pedersen BK (2005) Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33:114-119. (Pubitemid 40994563)
22. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, and Evans WJ (1990) High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 263:3029-3034. (Pubitemid 20181606)
23. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, and Evans WJ (1994) Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330:1769-1775. (Pubitemid 24177611)
24. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, et al. (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249-256.
25. Filaire E, Duché P, and Lac G (1998) Effects of amount of training on the saliva concentrations of cortisol, dehydroepiandrosterone and on the dehydroepiandrosterone: cortisol concentration ratio in women over 16 weeks of training. Eur J Appl Physiol Occup Physiol 78:466-471. (Pubitemid 28466766)
26. Freedman RJ, Malkovska V, LeRoith D, and Collins MT (2005) Hodgkin lymphoma in temporal association with growth hormone replacement. Endocr J 52:571-575. (Pubitemid 41609046)
27. 2max in older men. J Appl Physiol 68:329-333.
28. Gentry BA, Ferreira JA, Phillips CL, and Brown M (2011) Hindlimb skeletal muscle function in myostatin-deficient mice. Muscle Nerve 43:49-57.
29. Gilden D (1995) Human growth hormone available for AIDS wasting. GMHC Treat Issues 9:9-11.
30. 2+ in muscle cell damage. Ann NY Acad Sci 1066:166-180.
31. Hu H and Gatti RA (2008) New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicals. Curr Opin Allergy Clin Immunol 8:540-546.
32. Husom AD, Peters EA, Kolling EA, Fugere NA, Thompson LV, and Ferrington DA (2004) Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys 421:67-76. (Pubitemid 37543497)
33. Jähn K, Lara-Castillo N, Brotto L, Mo CL, Johnson ML, Brotto M, and Bonewald LF (2012) Skeletal muscle secreted factors prevent glucocorticoid- induced osteocyte apoptosis through activation of â-catenin. Eur Cell Mater 24:197-210.
34. Janssen I, Shepard DS, Katzmarzyk PT, and Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52:80-85. (Pubitemid 38090394)
35. Kren BT, Chen Z, Felsheim R, Roy Chowdhury N, Roy Chowdhury J, and Steer CJ (2002) Modification of hepatic genomic DNA using RNA/DNA oligonucleotides. Gene Ther 9:686-690. (Pubitemid 34591466)
36. Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, Alipour F, Shields RK, and Adams CM (2011) mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 13:627-638.
37. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122. (Pubitemid 44894520)
38. Lang TF (2011) The bone-muscle relationship in men and women. J Osteoporos 2011:702735.
39. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, and Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586-1591. (Pubitemid 46890428)
40. Ling CH, Taekema D, de Craen AJ, Gussekloo J, Westendorp RG, and Maier AB (2010) Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ 182:429-435.
41. Liu CJ and Latham NK (2009) Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009 Jul 8:CD002759.
42. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, and Hoffman AR (2007) Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 146:104-115. (Pubitemid 351640014)
43. Lukaski H (1997) Sarcopenia: assessment of muscle mass. J Nutr 127:994S-997S.
44. Magee P, Pearson S, and Allen J (2008) The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation. Lipids Health Dis 7:24.
45. Malafarina V, Uriz-Otano F, Iniesta R, and Gil-Guerrero L (2012) Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas 71:109-114.
46. Mo Q, Lu SF, and Simon NG (2006) Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. J Steroid Biochem Mol Biol 99:50-58.
47. Momken I, Stevens L, Bergouignan A, Desplanches D, Rudwill F, Chery I, Zahariev A, Zahn S, Stein TP, Sebedio JL, et al. (2011) Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. FASEB J 25:3646-3660.
48. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, et al. (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403-409.
49. Nelson SF, Crosbie RH, Miceli MC, and Spencer MJ (2009) Emerging genetic therapies to treat Duchenne muscular dystrophy. Curr Opin Neurol 22:532-538.
50. Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, Carter C, Di Bari M, Guralnik JM, and Pahor M (2002) Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 359:926-930. (Pubitemid 34246382)
51. Onder G, Vedova CD, and Pahor M (2006) Effects of ACE inhibitors on skeletal muscle. Curr Pharm Des 12:2057-2064. (Pubitemid 43821692)
52. Pathak AK, Bhutani M, Nair AS, Ahn KS, Chakraborty A, Kadara H, Guha S, Sethi G, and Aggarwal BB (2007) Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol Cancer Res 5:943-955. (Pubitemid 47416671)
53. Pedersen BK (2011) Muscles and their myokines. J Exp Biol 214:337-346.
54. Pedersen BK and Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88:1379-1406.
55. Pedersen BK and Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457-465.
56. Peng C, Chan HY, Huang Y, Yu H, and Chen ZY (2011) Apple polyphenols extend the mean lifespan of Drosophila melanogaster. J Agric Food Chem 59:2097-2106.
57. Recker R, Lips P, Felsenberg D, Lippuner K, Benhamou L, Hawkins F, Delmas PD, Rosen C, Emkey R, Salzmann G, et al. (2006) Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Curr Med Res Opin 22:1745-1755. (Pubitemid 44449231)
58. Romero-Suarez S, Shen J, Brotto L, Hall T, Mo C, Valdivia HH, Andresen J, Wacker M, Nosek TM, Qu CK, et al. (2010) Muscle-specific inositide phosphatase (MIP/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis. Aging (Albany NY) 2:504-513.
59. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990S-991S.
60. Sakuma K and Yamaguchi A (2012) Novel intriguing strategies attenuating to sarcopenia. J Aging Res 2012:251217.
61. Shishodia S, Majumdar S, Banerjee S, and Aggarwal BB (2003) Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with downregulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63:4375-4383. (Pubitemid 36951006)
62. Sumukadas D, Struthers AD, and McMurdo ME (2006) Sarcopenia-a potential target for angiotensin-converting enzyme inhibition? Gerontology 52:237-242. (Pubitemid 44114443)
63. Tadaishi M, Miura S, Kai Y, Kawasaki E, Koshinaka K, Kawanaka K, Nagata J, Oishi Y, and Ezaki O (2011) Effect of exercise intensity and AICAR on isoformspecific expressions of murine skeletal muscle PGC-1á mRNA: a role of β2- adrenergic receptor activation. Am J Physiol Endocrinol Metab 300:E341-E349.
64. Taekema DG, Gussekloo J, Maier AB, Westendorp RG, and de Craen AJ (2010) Handgrip strength as a predictor of functional, psychological and social health. A prospective population-based study among the oldest old. Age Ageing 39:331-337.
65. Thornton AM, Zhao X, Weisleder N, Brotto LS, Bougoin S, Nosek TM, Reid M, Hardin B, Pan Z, Ma J, et al. (2011) Store-operated Ca(2+) entry (SOCE) contributes to normal skeletal muscle contractility in young but not in aged skeletal muscle. Aging (Albany NY) 3:621-634.
66. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612-622.
67. Tokish JM, Kocher MS, and Hawkins RJ (2004) Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med 32:1543-1553. (Pubitemid 39100901)
68. Verschueren S, Gielen E, O'Neill TW, Pye SR, Adams JE, Ward KA, Wu FC, Szulc P, Laurent M, Claessens F, et al. (2012) Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int, http://dx.doi.org/10.1007/s00198-012-2057-z
69. Visser M and Schaap LA (2011) Consequences of sarcopenia. Clin Geriatr Med 27:387-399.
70. Weisleder N, Brotto M, Komazaki S, Pan Z, Zhao X, Nosek T, Parness J, Takeshima H, and Ma J (2006) Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J Cell Biol 174:639-645. (Pubitemid 44306720)
71. Wissing ER, Millay DP, Vuagniaux G, and Molkentin JD (2010) Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. Neuromuscul Disord 20:753-760.
72. Zhao X, Weisleder N, Thornton A, Oppong Y, Campbell R, Ma J, and Brotto M (2008) Compromised store-operated Ca2+ entry in aged skeletal muscle. Aging Cell 7:561-568. (Pubitemid 351998616)